Julphar announced as lead partner for the 14th edition of AIM Congress 2025 in Abu Dhabi
AIM Congress, supported by over 400 local, regional, and international partners, serves as a premier platform for fostering collaboration and advancing economic development through investment.
The Congress aims to unify global efforts, enhance strategic cooperation, and highlight the pivotal role of investment in driving innovation, economic growth, and the sustainability of key industries.
The strategic partnership between AIM Congress and Julphar underscores a shared commitment to strengthening collaborative initiatives, fostering knowledge exchange, and accelerating sustainable growth and digital transformation in the manufacturing sector.
This collaboration aligns with the UAE's vision to establish itself as a global hub for trade, manufacturing, and healthcare innovations, facilitating foreign direct investment (FDI) and reinforcing the country's leadership in the pharmaceutical industry.
Mr. Basel Ziyadeh, CEO of Gulf Pharmaceutical Industries (Julphar), expressed his enthusiasm for the partnership, stating:" For over four decades, Julphar has been at the forefront of the pharmaceutical industry, setting benchmarks for excellence and innovation while playing a vital role in shaping the UAE's pharmaceutical landscape."
Ziyadeh added: " We are honored to collaborate with the Emirates Drug Establishment (EDE) and AIM Congress, to drive impactful developmental strategies, promote teamwork, and cultivate partnerships that enhance equitable access to high-quality healthcare solutions. This collaboration contributes significantly to strengthening global, regional, and national health security."
Dawood Al-Shezawi, President of AIM Global Foundation and Chairman of the AIM Congress Organizing Committee, emphasized the importance of this partnership and its role in supporting AIM Congress objectives. He pointed out that collaborating with a leading company like Julphar enhances efforts to develop the industrial sector and supports the summit's vision of building a sustainable investment ecosystem that contributes to global economic development.
He also highlighted the vital role played by the pharmaceutical manufacturing sector in supporting national economies, strengthening healthcare security, and providing innovative solutions that improve quality of life. He noted that this partnership represents a strategic step towards advancing the pharmaceutical industry and attracting more investments to this crucial sector.
As one of the core portfolios of AIM Congress 2025, Global Manufacturing will focus on thetheme: 'From Industry 4.0 to 5.0: Leveraging Technology & Advancing Smart Factories.' The discussions will explore the transformation of manufacturing ecosystems, product innovation, operational efficiency, and sustainability. Key areas of focus include minimizing manual processes, optimizing resource utilization, ensuring worker safety, and enhancing productivity and competitiveness. The portfolio will also address how advanced technologies enable companies to navigate future challenges and unforeseen disruptions in an evolving global landscape.
The Global Manufacturing portfolio highlights the pharmaceutical industry as a key force in innovation, leveraging smart manufacturing, data analytics, and automation to enhance quality, efficiency, and sustainability.
By adopting cutting-edge technologies from the Fifth Industrial Revolution, pharmaceutical manufacturers are improving productivity, accelerating research and development, and reducing waste—helping to meet the rising demand for affordable medicines while ensuring long-term sustainability.
Beyond manufacturing, the industry plays a crucial role in global health security. Advanced technologies like artificial intelligence and the Internet of Things enhance quality control and product safety, while automation and digitalization improve supply chain efficiency, enabling faster responses to health crises.
Investing in this sector is essential for economic growth and community well-being, reinforcing its role as a pillar of innovation and resilience.
For more information, please visit: https://www.aimcongress.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
4 hours ago
- Gulf Today
Work requirements are a common-sense reform
Medicaid is the government programme that is supposed to help the poor afford health care. Its cost to taxpayers has skyrocketed in the last few years, consuming more than 12 percent of federal tax revenue collected by 2025. Projected Medicaid spending from 2025-2034 (before the One Big Beautiful Bill) was expected to total $8.2 trillion, $2.7 trillion more than if Medicaid had grown proportionally to the population and inflation, according to the Tribune News Service. Before the Affordable Care Act (Obamacare), Medicaid was a state-by-state programme and often was available only to a subset of people below the poverty line, especially mothers and children, but generally not working-age, work-capable adults. The ACA allowed states to expand Medicaid to cover every person below the poverty line and some above it, regardless of circumstances. The federal government pays 90% of the costs for those who became eligible due to the ACA expansion. Then, during the Biden administration, Congress and the president made a concerted effort to make enrolment easier, disenrolment harder, and programme integrity maintenance weaker. For states and private plans that insured beneficiaries, there was little downside to signing up ineligible people or keeping them once enrolled. And as a result, taxpayer money was unduly shovelled into the coffers of states, healthcare providers and insurance plans. This was a significant factor in the ballooning of Medicaid. That buildup undermined the core Medicaid mission of helping people most in need and rendered the programme less affordable to taxpayers, threatening to crowd out other priorities. That's why Congress included reforms in the One Big Beautiful Bill that would diminish abuse and put the programme back on a path to provide care for those who need it most. The new work requirements for Medicaid beneficiaries help accomplish this goal. Requiring able-bodied people to work as a condition for receiving this taxpayer-provided benefit is a common-sense reform. The work requirements don't apply to beneficiaries who are pregnant, differently-abled, a child, a senior, a parent of a child younger than 14, or those who are caretakers for others. The requirements are carefully targeted only at adults who can work and are only required in states that recently expanded Medicaid. Presumably, the work requirements will help identify and remove abuses like the 2.8 million duplicate enrolments that the Centers for Medicare & Medicaid Services identified. Many of these were Medicaid beneficiaries who remained enrolled in plans despite moving out of state and enrolling in their new home state. There is almost certainly more dubious enrolment to prune from the programme. Work requirements will make fraudulent enrolment, whether deliberate or incidental, even harder to sustain. Before the ACA, states eschewed coverage of capable adults because policymakers believed that people who could work should work, reserving the safety net for those who were unable. It was a work requirement by default. Now that Medicaid is available to everyone, though, a narrowly targeted work requirement is a reasonable reform. Critics fear work requirements will impose a paperwork burden on eligible beneficiaries that will lead to massive reductions in Medicaid enrollment and, ultimately, adverse health consequences. However, these criticisms are based on scant evidence from two states: one that didn't have enough time to set up and perfect its system before a court ended it, and the other was an add-on program. Neither state imposed the requirements as envisioned in the just-passed Big Beautiful Bill. In any case, paperwork burdens will likely not present a big problem, as private insurance companies are paid for each Medicaid enrollee and have strong incentives to ensure that everyone eligible remains signed up. The Medicaid programme desperately needs reforms to make sure benefits go to the people who need them most and at a cost that is manageable for taxpayers. Work requirements help achieve that goal without endangering access for those who need it.
Web Release
9 hours ago
- Web Release
World FZO Brings its 12th World Congress to Panama in 2026
The World Free Zones Organization announced the signing of a Memorandum of Understanding with the government of Panama to host the 12th annual World FZO's World Congress in the country's capital, Panama City, in July 2026. The MoU was signed by His Excellency Dr. Mohammed AlZarooni, Chairman of the World FZO, and His Excellency Julio Molto', Minister of Commerce and Industries at the Government of the Republic of Panama, in the presence of senior officials from both sides. The announcement was made during an official visit led by Dr. AlZarooni to Panama City, where he met with His Excellency José Raúl Molino Quintero, President of the Republic of Panama. On the sidelines of the visit, the delegation toured key sites in Panama, including the Colón Free Trade Zone, PANAPARK Free Zone, and the Panama Canal. Under the MoU, both parties will collaborate to deliver a high-caliber edition of the World FZO World Congress, that convenes decision-makers, freezone leaders, and investors from more than 100 countries, in addition to attracting major economic institutions from around the world. The event is expected to strengthen Panama's global standing as a hub for trade and logistics and enhance its visibility on the international investment map. H.E. Dr. AlZarooni, said: 'World FZO is committed to forging strategic partnerships that enhance the role of freezones as drivers of global growth, based on the importance of developing platforms for international dialogue and cooperation to keep up with the major shifts taking place in the global economy. Our cooperation with the government of Panama represents a key milestone in our efforts to outreach to Latin American markets and strengthen cooperation with governments and economic institutions in this vital region.' HE Julio Molto', said: 'Hosting the Congress represents a strategic step that highlights Panama's position as a global investment gateway and opens new prospects for regional cooperation, technology, and investment. We are committed to providing all necessary elements to ensure the success of this crucial event, in cooperation with the Organization. We value our partnership with World FZO and look forward to leveraging its extensive experience in the development and administration of freezones internationally, which will enhance the competitiveness of Panama's business environment and open our economy to global markets.' This announcement comes as preparations continue for the 11th World FZO Congress, set to take place in Hainan province, China, from 10–12 October 2025, held with the Hainan International Economic Development Bureau. The back-to-back hosting of the Congress in both China and then Panama reflects the growing momentum of the World FZO on the international stage. .The World FZO World Congress is the world's premier gathering of freezone leaders, government officials, investors, and trade experts. It gathers more than 1,500 delegates from over 100 countries, bringing together a select group of decision-makers, and high-level representatives from global industry, trade, and investment sectors.
Dubai Eye
a day ago
- Dubai Eye
India PM Modi faces opposition fury after Trump's 25% tariff threat
Indian opposition parties criticised the government on Thursday, describing US President Donald Trump's threat of a 25 per cent tariff as a diplomatic failure for New Delhi, while the rupee currency tumbled and equity indexes slid in response to the news. The 25 per cent rate would single out India more harshly than other major trading partners, and threatens to unravel months of talks, undermining one of Washington's strategic partners in the region, viewed as a counterbalance to China. Trump said the tariff on goods imports from India would start from Friday, in addition to an unspecified penalty for Russian dealings and involvement in the BRICS grouping of nations, but added later that trade talks continued. In response, the government of Prime Minister Narendra Modi said it was studying the implications of Trump's remarks and was dedicated to securing a fair trade deal. "This development reflects a broader collapse of foreign policy under the Modi government," a lawmaker of the main opposition Congress said in a notice asking for a discussion of the matter in the lower house. The debate would focus on the "government's economic and diplomatic failure in preventing the imposition of 25 per cent US tariffs plus penalties on Indian exports," it added. Commerce Minister Piyush Goyal is expected to brief the lower house later on Thursday, television news channels said. Economists warned the steep tariff could hurt India's manufacturing ambitions and trim up to 40 basis points from economic growth in the financial year to March 2026. India's benchmark equity indices, the Nifty 50 and BSE Sensex, fell about 0.6 per cent each, while the rupee declined to 87.74, its lowest in more than five months, before paring losses. India has received a "raw deal", said Priyanka Kishore, an economist at Asia Decoded. "While further trade talks may bring the tariff rate down, it appears unlikely that India will secure a significantly better outcome than its eastern neighbours," she added. That would raise questions about India's relative appeal as a China plus one destination, she said, referring to a strategy of diversifying supply chains through manufacturing outside China to reduce geopolitical and operational risks. Trade talks continued, Trump said on social media, however, as nations face a Friday deadline to strike deals on reciprocal tariffs or have a US tariff slapped on their exports. The US levy on India exceeds those achieved by some other nations in deals with the Trump administration. For example, the tariff on Vietnam is set at 20 per cent and on Indonesia at 19 per cent, with levies of 15 per cent on Japanese and European Union exports. On Wednesday, Trump said Washington had reached a trade deal with India's arch-rival Pakistan that Islamabad said would lead to lower tariffs on its exports, but neither side have yet revealed the agreed rate. Since India's short but deadly conflict with Pakistan in May, New Delhi has been unhappy about Trump's closeness with Islamabad and has protested, casting a shadow over trade talks. Despite former public displays of bonhomie between Trump and Modi, India has taken a slightly harder stance against the United States in recent weeks. Trump has repeatedly taken credit for the India-Pakistan ceasefire he announced on social media on May 10, but India disputes his claim that it resulted from his intervention and trade threats. "The country is now bearing the cost of Narendra Modi's friendship," Congress said. The United States, the world's largest economy, now has a trade deficit of $45.7 billion with India, the fifth largest.
